Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H11NO2 |
Molecular Weight | 153.1784 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NCCC1=CC(O)=C(O)C=C1
InChI
InChIKey=VYFYYTLLBUKUHU-UHFFFAOYSA-N
InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2
Molecular Formula | C8H11NO2 |
Molecular Weight | 153.1784 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:09:29 UTC 2023
by
admin
on
Fri Dec 15 15:09:29 UTC 2023
|
Record UNII |
VTD58H1Z2X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C88516
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
13733-1
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
DSLD |
4132 (Number of products:1)
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
NDF-RT |
N0000007715
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
14703-3
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
15058-1
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
25906-9
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
12.4
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
2217-8
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
24524-1
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
2218-6
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
2216-0
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
44316-8
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
15059-9
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
WHO-ATC |
C01CA04
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
33873-1
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
74904-4
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
NDF-RT |
N0000175570
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
27212-0
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
WHO-VATC |
QC01CA04
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
||
|
LOINC |
44918-1
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D004298
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
DTXSID6022420
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
VTD58H1Z2X
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
Dopamine (medication)
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
200-110-0
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
DOPAMINE
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
C62025
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
100000080782
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
681
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
3068
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
CHEMBL59
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
VTD58H1Z2X
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
3628
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | RxNorm | ||
|
m4740
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | Merck Index | ||
|
59905
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
940
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
173182
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
Dopamine
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
2417
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
DB00988
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
51-61-6
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
947
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
SUB06365MIG
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY | |||
|
18243
Created by
admin on Fri Dec 15 15:09:29 UTC 2023 , Edited by admin on Fri Dec 15 15:09:29 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
BINDING
IC50
|
||
|
TARGET -> AGONIST |
D2R concentration levels were significantly lower in AD patients than in healthy controls (SMD = −1.13, 95%CI: −1.52 to −0.74), with low heterogeneity (I2 = 7.80%), when USA studies were considered.
|
||
|
CONSTITUENT ALWAYS PRESENT -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
ACTIVATOR OF RELEASE->TARGET |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
PLASMA; URINE
|
||
|
PRODRUG -> METABOLITE ACTIVE |
MAJOR
|
||
|
METABOLITE INACTIVE -> PARENT |
|
||
|
METABOLITE TOXIC -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PARENT -> METABOLITE ACTIVE |
MINOR
|
||
|
METABOLITE TOXIC -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|